The biological and clinical relevance of anti-metalloproteinase-9 antibody (GS-5745) in treatment of ulcerative colitis patients

被引：0
|
作者：
Bhandari, B. R. [1 ]
Lee, S. [2 ]
Zhao, X. [3 ]
Huntzicker, E. [3 ]
Guo, X. [3 ]
Jiang, Z. [3 ]
Ge, D. [3 ]
French, D. [3 ]
Subramanian, M. [3 ]
McHutchison, J. G. [3 ]
Kanwar, B. [3 ]
Levesque, B. [4 ]
Sandborn, W. [4 ,5 ]
机构：
[1] Delta Res Partners LLC, Monroe, LA USA
[2] Univ Washington, Seattle, WA 98195 USA
[3] Gilead Sci Inc, 353 Lakeside Dr, Foster City, CA 94404 USA
[4] Univ Western Ontario, Robarts Clin Trials, London, ON, Canada
[5] Univ Calif San Diego, San Diego, CA 92103 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2016年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P721
引用
收藏
页码：S473 / S474
页数：2
相关论文
共 35 条
  • [31] Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn's disease patients: a German retrospective chart review
    Helwig, Ulf
    Mross, Michael
    Schubert, Stefan
    Hartmann, Heinz
    Brandes, Alina
    Stein, Dara
    Kempf, Christian
    Knop, Jana
    Campbell-Hill, Sarah
    Ehehalt, Robert
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [32] HIGHER SERUM ALBUMIN IS ASSOCIATED WITH STEROID-FREE CLINICAL REMISSION AMONG ULCERATIVE COLITIS PATIENTS INITIATING TOFACITINIB THERAPY AFTER ANTI-TUMOR NECROSIS FACTOR ALPHA AND ANTI-INTEGRIN TREATMENT FAILURE
    Dalal, Rahul S.
    McClure, Emma L.
    Allegretti, Jessica R.
    GASTROENTEROLOGY, 2021, 160 (06) : S549 - S550
  • [33] Real-world clinical effectiveness and safety of vedolizumab and anti-tumor necrosis factor alpha treatment in ulcerative colitis and Crohn’s disease patients: a German retrospective chart review
    Ulf Helwig
    Michael Mross
    Stefan Schubert
    Heinz Hartmann
    Alina Brandes
    Dara Stein
    Christian Kempf
    Jana Knop
    Sarah Campbell-Hill
    Robert Ehehalt
    BMC Gastroenterology, 20
  • [34] Effectiveness of adalimumab for the treatment of ulcerative colitis in clinical practice: comparison between anti-tumour necrosis factor-naive and non-naive patients (vol 52, pg 788, 2017)
    Iborra, Marisa
    Gisbert, Javier P.
    Bosca-Watts, Marta Maia
    Lopez-Garcia, Alicia
    Garcia-Sanchez, Valle
    Lopez-Sanroman, Antonio
    Hinojosa, Esther
    Marquez, Lucia
    Garcia-Lopez, Santiago
    Chaparro, Maria
    Aceituno, Montserrat
    Calafat, Margalida
    Guardiola, Jordi
    Belloc, Blanca
    Ber, Yolanda
    Bujanda, Luis
    Beltran, Belen
    Rodriguez-Gutierrez, Cristina
    Barrio, Jesus
    Luis Cabriada, Jose
    Rivero, Montserrat
    Camargo, Raquel
    van Domselaar, Manuel
    Villoria, Albert
    Schuterman, Hugo Salata
    Hervas, David
    Nos, Pilar
    JOURNAL OF GASTROENTEROLOGY, 2017, 52 (07) : 875 - 877
  • [35] Add-on multiple submucosal injections of the RNA oligonucleotide GUT-1 to anti-TNF antibody treatment in patients with moderate-to-severe ulcerative colitis: an open-label, proof-of concept study
    Suzuki, Kenji
    Sameshima, Yukinori
    Yokoyama, Junji
    Terai, Shuji
    Yoneyama, Hiroyuki
    Atreya, Raja
    Neurath, Markus F.
    Hibi, Toshifumi
    Asakura, Hitoshi
    INFLAMMATION AND REGENERATION, 2024, 44 (01)
1234